Established in 2010, Proveca is a specialist pharmaceutical company which focuses on developing innovative, technically complex, demand driven pharmaceuticals.

Proveca has been established following the successfull sale of the founding directors former company Auralis Ltd to Viropharma Ltd. With this proven track record of successfully taking complex products from conception to commercialisation, Proveca maintains a specific focus on ensuring the availability and appropriate presentation of important medicinal products which will address unmet medical needs.

Proveca's portfolio of products in development focus on developing essential medicines for children and adults, through studies dedicated to providing evidence for the specific use of off-patent medicines.